The office of the Brigham Health President, in concert with BH Department Chairs, has made funds available beginning in FY20 to support a new program to establish or contribute to research sundry funds for BWH investigators who obtain multi-year non-mentored NIH grants. No application is required; monies will be available for awards made on or after October 1, 2019.
Summary: The Football Players Health Study is currently soliciting proposals for innovative “ultra near-term” solutions to improve the health of former and/or current professional football players. Examples of solutions include the application of imaging, sensing, diagnostic, preventative, or therapeutic technologies. Successfully funded awards will emphasize improving health by applying a technology to either prevent or treat a medical condition that has a high prevalence among American-style football (ASF) players. These conditions may include, for example, sleep apnea, cardiometabolic and cardiovascular disease, neurocognitive impairment, musculoskeletal injury, or chronic pain.
Summary: The KL2/Catalyst Medical Research Investigator Training (CMeRIT) program provides advanced training in clinical and translational research to senior fellows and junior faculty from all health professions represented by Harvard Catalyst, including medicine, dentistry, and nursing.Awardees will pursue a mentored research project in their area of expertise. It is expected that the research performed within the KL2/CMeRIT program will provide the basis for an independent NIH award (e.g., K23, KO8, or RO1).
Awardees will also pursue an educational program that fulfills the mission of the program and provides optimal training in their chosen career objectives. They may do this by taking part in the courses found in LearnResearch where applicable, or by participating in Harvard Catalyst-based courses.
Amount: Up to 2 awards of up to $50,000 (direct cost) will be made for the funding period from 8/1/20 – 7/31/21
Deadline: May 1, 2020, 5PM
Summary: The Leukemia Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Career Enhancement Program (CEP) projects focused on adult or pediatric myeloid malignancies. Funding will be provided for up to two awards through the National Cancer Institute (NCI)-sponsored Specialized Program of Research Excellence (SPORE) mechanism.
Amount: 2 awards of up to $100,000 in annual direct costs
Deadline: May 1, 2020, 5PM
Summary: The Dana-Farber/Harvard Cancer Center Specialized Program in Research Excellence (SPORE) seeks applications for Developmental Research Project Awards in Myeloid Malignancies. The objective of the Developmental Research Program is to identify and fund new ideas and projects for the SPORE in Myeloid Malignancies.
Amount: Up to $2,000 Deadline: Applications will be accepted on a rolling basis Eligibility: Health care professionals seeking learning opportunities, including post-docs, residents, clinical fellows and medical students who are part of the Partners system Summary: The awards provide funding to health care professionals and learners to help them develop their knowledge, networks and understanding of traumatic injury and identify subjects where they can pursue research and treatment ideas.
The Broad Institute of MIT and Harvard and the BWH Program in Precision Medicine
Amount: May fund one grant at a maximum of $100K (including 15% indirect costs) for one year
Deadline: Postponed; new date TBD
Eligibility: Targeted to junior investigators: postdoctoral research fellows, clinical fellows, Instructors or Assistant Professors within 2 years of their appointment
Summary: The Broad Institute of MIT and Harvard (Broad Institute) and the Brigham and Women’s Hospital (BWH) Program in Precision Medicine invites applications for the 2020 cycle of the Sperling Family Fellowship. The purpose of this funding program is to provide resources for innovative projects with the goal of leveraging the strengths of two world-renowned institutions— the superb clinical care, expert bioinformatics, and rich data sources of BWH, and the basic science, computational, and genomics sophistication of the Broad Institute – to advance a translational research project with the potential to transform how we care for patients.